ArthroMeda, formerly ArthroCAD, brings in $1.6 million of a hoped-for $2 million in its latest funding round.
ArthroMeda hauled in $1.6 million in an equity offering it hoped would raise $2 million, according to a regulatory filing.
Ayer, Mass.-based ArthroMeda develops devices used in total hip arthroplasties that are designed to help physicians properly orient hip implants. The company was hoping to bring in $2 million through the equity sale. ArthroMeda brought in 12 backers, according to a regulatory filing.
Founded in 2011 as ArthroCAD, ArthroMeda pulled in a Series A round worth $695,000 last year, according to a separate filing.
